Over €30 million in Government funding has been allocated to nine innovative medical and health-related projects in Galway.

The funding of €95 million nationally has been allocated by the Tánaiste, Leo Varadkar as part of the latest round of the Disruptive Technologies Fund, one of the Project Ireland 2040 funds which aims to support innovative, ground-breaking projects which in turn help create high-quality jobs.

Almost one third of the national funding from this round of the Disruptive Technologies Fund is coming to Galway. The €30.24 million will help Galway-based MedTech and Lifesciences companies, in partnership with higher educational institutions like NUI Galway, develop new treatments for illnesses and conditions.

The projects, several of which are led by Údarás na Gaeltachta client companies, will see new treatments for osteoarthritis and gastrointestinal cancer, new medical devices for the treatment of cardiac and vascular conditions, lung cancer and lung conditions as well as a project that will alleviate a side effect – hair loss – of chemotherapy. A further project involves the development of drones for medical deliveries which will benefit the environment as well as patients.

Back in 2015 when we launched the Action Plan for Jobs for the West one of the main aims was to strengthen and develop clusters in MedTech, Lifesciences and ICT in Galway and the West. This aim was further developed in successive Regional Enterprise Action Plans and has involved co-ordinating the work of State agencies like Údarás, the IDA and Enterprise Ireland in supporting Galway-based companies and supporting cutting edge research at our local higher education institutions like NUIG and GMIT.

Today’s funding allocation proves the success of that approach and shows that Galway has a strong, vibrant and thriving MedTech and Lifesciences cluster which supports high-quality jobs and has great potential in the years ahead.

Project DescriptionConsortium MembersResearch Priority AreaRegional LocationTotal DTIF Award*
A complete regenerative treatment for knee osteoarthritis   using a hydrogel-based therapeutic  1) Relevium Medical Ltd; 2) HiTech Health Ltd; 3) National University of Ireland, Galway (NUIG)Health and WellbeingGalway€7.0m
Project DescriptionConsortium MembersResearch Priority AreaRegional LocationTotal DTIF Award*
Outpatient solution without side effects to deliver next generation therapeutic and gene therapies for gastrointestinal cancer    1) Mirai Medical Ltd; 2) Excelsys Technologies Ltd; 3) National University of Ireland Galway (NUIG); 4) Trinity College Dublin (TCD); 5) National University of Ireland Cork (UCC)Health & WellbeingGalway€4.78m
Development and commercialisation of sutureless polymeric transcatheter heart valve technology1) Aran Biomedical Teoranta; 2) Lifelet Medical Ltd; 3) National University of Ireland, Galway (NUIG)Health and WellbeingGalway€2.94m
RELAY will develop and commercialise a disruptive large-bore vascular closure device that will become the new standard of care for catheter-based surgeries  1) Prelude Medical Ltd; 2) Theradep Ltd; 3) Technology University Dublin (TUD)Health and WellbeingGalway€2.89m  
A smart, patient-centric catheter-based solution for treating malignant pleural effusion “fluid on the lung” in the home resulting in improved autonomy of care  1) SymPhysis Medical Ltd; 2) Gentian Consultancy Services Ltd; 3) National University of Ireland, Galway (NUIG); 4) Galway University HospitalHealth and WellbeingGalway€2.87m  
Develop a minimally invasive and intelligent microwave ablation catheter for treatment of lung cancer  1) Endowave Ltd; 2) Quadrant Scientific Ltd; 3) National University of Ireland, Galway (NUIG)Health and WellbeingGalway€2.68m
Develop a treatment for chronic knee osteoarthritis, to deliver dramatic pain and mobility benefits to patients    1) CrannMed Ltd; 2) Innovative Catheter Solutions Ltd; 3) Creganna Unlimited Company; 4) Technology University Dublin (TUD)Health and Wellbeing  Galway€2.47m
The MI-DRONE project will address consumer demand for fast, reliable, last-mile delivery using a drone. It will reduce delivery time to 3 mins and decrease emissions by 80%  1) ÉireComposites Teoranta; 2) Manna Drones Ltd; 3) National University of Ireland, Galway (NUIG)Manufacturing & MaterialsGalway€2.44m
The LILY project will deliver the world’s first pain-free, patient-led treatment to prevent Chemotherapy Induced Alopecia, considerably improving the quality of life of patients undergoing chemotherapy  1) Luminate Medical Ltd; 2) Gentian Consultancy Services Ltd; 3) National University of Ireland, Galway (NUIG)Health and WellbeingGalway€2.17m